# Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC

> **NCT02990780** · PHASE3 · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 266 (estimated)

## Conditions studied

- SCLC

## Interventions

- **RADIATION:** Conventionally fractionated concurrent chemo-radiotherapy
- **RADIATION:** Accelerated hypofractionated concurrent chemo-radiotherapy

## Key facts

- **NCT ID:** NCT02990780
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 266 (ESTIMATED)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02990780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02990780, "Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02990780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*